🇺🇸 FDA
Patent

US 9487493

Use of a PPAR-delta agonist for treating muscle atrophy

granted A61KA61K31/192A61K31/5375

Quick answer

US patent 9487493 (Use of a PPAR-delta agonist for treating muscle atrophy) held by VTV THERAPEUTICS LLC expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/192, A61K31/5375, A61K9/0053, A61P